scholarly journals Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding: A German Hospital Perspective

2015 ◽  
Vol 18 (7) ◽  
pp. A369
Author(s):  
N Jamous ◽  
O Martini ◽  
N Ferko ◽  
A Hogan ◽  
M Corral
2013 ◽  
Vol 16 (7) ◽  
pp. A380
Author(s):  
M. Corral ◽  
N. Ferko ◽  
S. Hollmann ◽  
P. Delatore ◽  
N. Jamous ◽  
...  

2015 ◽  
Vol 18 (3) ◽  
pp. A40
Author(s):  
M. Corral ◽  
N. Jamous ◽  
N. Ferko ◽  
A. Hogan ◽  
J. Batiller ◽  
...  

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Astha Srivastava ◽  
Ankur Srivastava

AbstractIn accident law, we seek a liability rule that will induce both the parties to adopt socially optimal levels of precaution. Economic analysis, however, shows that none of the commonly used liability rules induce both parties to adopt optimal levels, if courts have access only to ‘Limited Information’ on. In such a case, it has also been established (K. (2006). Efficiency of liability rules: a reconsideration. J. Int. Trade Econ. Dev. 15: 359–373) that no liability rule based on cost justified untaken precaution as a standard of care can be efficient. In this paper, we describe a two-step liability rule: the rule of negligence with the defence of relative negligence. We prove that this rule has a unique Nash equilibrium at socially optimal levels of care for the non-cooperative game, and therefore induces both parties to adopt socially optimal behaviour even in case of limited information.


2021 ◽  
Vol 26 (01) ◽  
pp. 15-15

van Katwyk S et al. Economic Analysis of Exclusive Human Milk Diets for High-Risk Neonates, a Canadian Hospital Perspective. Breastfeed Med 2020; 15 (6): 377–386. DOI: 10.1089/bfm.2019.0273 Frühgeborene profitieren hinsichtlich einer Vielzahl potenzieller Komplikationen, beispielsweise der nekrotisierenden Enterokolitis, der Retinopathie, der Sepsis sowie der bronchopulmonalen Dysplasie, von einer ausschließlichen Ernährung mit humaner Milch, bei welcher die Milch der eigenen Mutter bzw. Donormilch mit aus pasteurisierter Spendermilch gewonnenem Fortifier angereichert wird. Ist dieses Vorgehen auch unter Kostenaspekten vertretbar?


Sign in / Sign up

Export Citation Format

Share Document